Stay updated on Ixazomib Combo in Relapsed/Refractory MM Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page.

Latest updates to the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new page revision entry v3.5.4 has been added, and the previous entry v3.5.3 has been removed, updating the page's displayed version in the footer.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedThis update only changes the site’s displayed revision/version indicator from v3.5.0 to v3.5.3, with no indication of changes to the clinical trial’s history or study details.SummaryDifference0.1%

- Check76 days agoChange DetectedA new revision entry, v3.5.0, was added to the history and revision v3.4.3 was removed.SummaryDifference0.1%

- Check90 days agoChange DetectedAdded Oversight and Study Status entries on 2026-03-05 and updated the record to Revision v3.4.3; the previous revision v3.4.2 (2025-09-09) was removed.SummaryDifference0.6%

- Check112 days agoChange DetectedA new revision entry 'Revision: v3.4.2' was added to the Study Record Versions, replacing the previous v3.4.1 entry. This update appears to be a release-note style change rather than a modification of study data.SummaryDifference0.1%

- Check119 days agoChange DetectedThe Record History page shows a new revision entry, v3.4.1, and removes the previous revision, v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Ixazomib Combo in Relapsed/Refractory MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page.